Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With Schizophrenia
Clinical trial NCT03238326 · COMPLETED
Trial details
- NCT number
- NCT03238326
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-23
- Primary completion
- 2025-04-22
- Enrollment
- 295
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.